Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Inventory (2016 - 2024)

Historic Change in Inventory for Perspective Therapeutics (CATX) over the last 15 years, with Q2 2024 value amounting to $16000.0.

  • Perspective Therapeutics' Change in Inventory rose 20000.0% to $16000.0 in Q2 2024 from the same period last year, while for Jun 2025 it was $16000.0, marking a year-over-year increase of 10707.96%. This contributed to the annual value of -$359000.0 for FY2023, which is 11798.6% down from last year.
  • According to the latest figures from Q2 2024, Perspective Therapeutics' Change in Inventory is $16000.0, which was up 20000.0% from -$27000.0 recorded in Q1 2024.
  • In the past 5 years, Perspective Therapeutics' Change in Inventory ranged from a high of $1.9 million in Q2 2022 and a low of -$1.3 million during Q4 2021
  • Moreover, its 5-year median value for Change in Inventory was $22000.0 (2020), whereas its average is $83647.1.
  • Over the last 5 years, Perspective Therapeutics' Change in Inventory had its largest YoY gain of 116349.21% in 2021, and its largest YoY loss of 583636.36% in 2021.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Change in Inventory stood at $22000.0 in 2020, then crashed by 5836.36% to -$1.3 million in 2021, then soared by 106.02% to $76000.0 in 2022, then crashed by 234.21% to -$102000.0 in 2023, then skyrocketed by 115.69% to $16000.0 in 2024.
  • Its Change in Inventory stands at $16000.0 for Q2 2024, versus -$27000.0 for Q1 2024 and -$102000.0 for Q4 2023.